Drug Pricing Intelligence (POLI) Database

GlobalData’s Drug Pricing Intelligence (POLI) package provides an exhaustive source of drug prices and costs, allowing clients to access full price history time-series for three price levels (manufacturer, wholesaler, and retail) to help compare prices and therapy costs by geography and therapeutic area. The POLI pricing database covers: - 80 markets in-depth with analyses based on pharmaceutical name, dosage, regulation, phases & timings, ingredients, costs, and prices for all therapeutics. - Prices are reported in local currency with conversion available into any currency, allowing easy comparison of prices for hospital and retail pharmaceuticals globally to gain insight into broader pricing trends by geography and therapeutic area. Data coverage also includes a Therapeutics View that breaks down the pricing data into critical and detailed cost, narrowed down to the indication level. Data points include: - Dates of reimbursement decision per indication - Average costs of treatment, and reimbursements per indication - HTA agencies per indication - Annual costs of therapy for products on market This provides clients with the ability to compare the cost of multiple medicines for the same indication or compare the costs of a particular medicine across all approved indications.GlobalData旗下药品定价情报（POLI）套件提供全面详尽的药品价格与成本数据源，助力客户获取制造商、批发商、零售终端三个价格层级的完整价格历史时序数据，以便对比不同地域与治疗领域的药品价格及治疗成本。 POLI定价数据库覆盖80个深度市场，基于药品名称、剂型、监管政策、研发阶段与时间线、活性成分、成本及价格等维度，对所有治疗药物开展系统性分析。 所有价格均以当地货币报送，并支持转换为任意币种，便于开展全球范围内医院与零售药房药品的价格对比，进而洞悉不同地域及治疗领域的整体定价趋势。 数据覆盖范围还包含治疗药物视图模块，可将定价数据拆解为关键详实的成本维度，并细化至适应症层级。 数据点涵盖： - 各适应症的医保报销决策日期 - 各适应症的平均治疗成本与医保报销金额 - 各适应症对应的卫生技术评估（Health Technology Assessment, HTA）机构 - 上市药品的年度治疗成本 该套件可支持客户对比同一适应症下多款药物的治疗成本，或对比同一款药物在所有获批适应症间的治疗成本差异。

搜集汇总

背景与挑战

背景概述

Drug Pricing Intelligence (POLI) Database是一个全面的药物价格和成本数据源，提供三个价格层次（制造商、批发商和零售）的完整价格历史时间序列，覆盖80个市场，支持按地理和治疗领域比较价格和治疗成本。数据集还包括治疗视图，提供详细的成本分析，如适应症级别的报销决策日期、治疗平均成本和报销信息，便于跨药物和适应症的成本比较。